Search Results - "Fernández Pajarín, Gustavo"

Refine Results
  1. 1

    Delayed complications of deep brain stimulation: 16-year experience in 249 patients by Fernández-Pajarín, Gustavo, Sesar, A., Ares, B., Relova, J. L., Arán, E., Gelabert-González, M., Castro, A.

    Published in Acta neurochirurgica (01-09-2017)
    “…Background Over the years, most of the deep brain stimulation (DBS) complications described have been mainly related to the surgery itself or the stimulation…”
    Get full text
    Journal Article
  2. 2

    Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson’s disease: A prospective study of 22 patients by Fernández-Pajarín, Gustavo, Sesar, Ángel, Jiménez Martín, Isabel, Ares, Begoña, Castro, Alfonso

    Published in Clinical parkinsonism & related disorders (01-01-2022)
    “…•A prospective analysis of APO treatment of 22 PD patients in the initial stages of advanced PD.•Motor and non-motor symptoms, cognitive function and quality…”
    Get full text
    Journal Article
  3. 3

    Do we need to redefine the advanced stage in Parkinson’s disease? by Sesar, Ángel, Fernández-Pajarín, Gustavo, Ares, Begoña, Castro, Alfonso

    Published in Revista mexicana de neurociencia (01-10-2021)
    “…Abstract Identifying the advanced stage in Parkinson’s disease (PD) is crucial for shifting from conventional to device-aided therapies. The criteria to define…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Parkinson's Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation by Fernández-Pajarín, Gustavo, Sesar, Ángel, Relova, José Luis, Ares, Begoña, Jiménez, Isabel, Gelabert-González, Miguel, Arán, Eduardo, Castro, Alfonso

    Published in Diagnostics (Basel) (15-04-2022)
    “…Background: The relationship between axial symptoms in Parkinson’s disease (PD) and subthalamic deep brain stimulation (STN-DBS) is still unclear. Purpose: We…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients by Sesar, Ángel, Fernández-Pajarín, Gustavo, Ares, Begoña, Rivas, María Teresa, Castro, Alfonso

    Published in Journal of neurology (01-05-2017)
    “…Continuous apomorphine infusion (APO) is one of the treatments available for advanced Parkinson disease (PD). Over 10 years, we have treated 230 patients with…”
    Get full text
    Journal Article
  8. 8

    Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation by Sesar, Ángel, Fernández-Pajarín, Gustavo, Ares, Begoña, Relova, José-Luis, Arán, Eduardo, Rivas, María-Teresa, Gelabert-González, Miguel, Castro, Alfonso

    Published in Journal of neurology (01-03-2019)
    “…Introduction Deep brain stimulation (DBS) is an effective therapy for patients with advanced Parkinson’s disease (PD). However, sometimes, it is not sufficient…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study by Fernández-Pajarín, Gustavo, Sesar, Ángel, Ares, Begoña, Castro, Alfonso

    Published in Journal of Parkinson's disease (01-01-2016)
    “…There are not many data about the beneficial effect of nocturnal continuous subcutaneous apomorphine infusion (NCSAI) over sleep disturbances in advanced…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Is necessary to perform a transthoracic echocardiogram in all the patients with cryptogenic stroke during hospitalization? by Arias-Rivas, Susana, Rodríguez-Yáñez, Manuel, López-Ferreiro, Ana, Santamaría-Cadavid, María, Fernández-Pajarín, Gustavo, González-Juanatey, José Ramón, Castillo, José, Blanco, Miguel

    Published in Revista de neurologiá (16-05-2013)
    “…From 15 to 30% of all ischemic strokes are cardioembolic. Transthoracic echocardiography plays a key role in the evaluation, diagnosis and management of the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study by Santos García, Diego, Fernández Pajarín, Gustavo, Oropesa-Ruiz, Juan Manuel, Escamilla Sevilla, Francisco, Rahim López, Raúl Rashid Abdul, Muñoz Enríquez, José Guillermo

    Published in Brain sciences (12-03-2022)
    “…Patients with Parkinson’s disease (PD) can improve some non-motor symptoms (NMS) after starting treatment with opicapone. The aim of this study was to analyze…”
    Get full text
    Journal Article
  19. 19
  20. 20